Salarius raises $6.2M; believes Nasdaq equity compliance regained ahead of Oct 20 deadline

Decoy Therapeutics Inc.

Raised $2.4M from ATM sales (434,882 shares) and $3.8M from C/M Capital Master Fund purchase agreement.
Believes stockholders' equity now exceeds $2.5M as of Oct 6, 2025; awaiting Nasdaq confirmation.
Previously faced Nasdaq delisting risk if compliance not met by Oct 20, 2025.
Q3 10-Q expected to reflect equity above $2.5M as of Sept 30, 2025.

item 8.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001615219-25-000142
form_type: 8-K
ticker: DCOY
cik: 0001615219
company_name: Decoy Therapeutics Inc.
filed_at: 2025-10-06T23:59:59+00:00
discovered_at: 2026-05-14T18:02:39.926143+00:00
generated_at: 2026-05-17T04:35:15.628457+00:00
sec_items: ["8.01"]
event_type: other_material
sentiment: positive
materiality_score: 0.65
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001615219-25-000142
json_url: https://secwatch.observer/filing/0001615219-25-000142.json
markdown_url: https://secwatch.observer/filing/0001615219-25-000142.md
text_url: https://secwatch.observer/filing/0001615219-25-000142.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1615219/000161521925000142/0001615219-25-000142-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1615219/000161521925000142/flks-20251006.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001615219-25-000142

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.